Editorially independent content supported by advertising by Allergan, an AbbVie company.
Ahead of the Curve
David Goldman, MD; Alice Epitropoulos, MD; Scott Schacter, OD; and Mary Pat Johnson share their insights on the advantages and obstacles to expect during the transition to telemedicine.
Next VideoListen as a Podcast
Listen to Policy, Practice and Promise: Billing and Coding for Telemedicine in the COVID-19 Era as a podcast in the CRST: The Podcast feed.
For further resources on billing and coding in telemedicine, please visit this digital supplement page.
This program consists of editorially independent content supported by advertising by Allergan, an AbbVie company. The opinions and views expressed
during this program are those of the individual participants and are not necessarily those of Allergan, an AbbVie company or its affiliates.
Editorially Independent Program Produced By
